Surgify Medical

Executive Summary

Surgify Medical is a Finnish medical device company founded in 2017, pioneering ultrasonic bone surgery technology with its Surgify Halo™ system. The device addresses critical limitations of conventional bone cutting methods—such as mechanical saws and drills—by offering enhanced precision, reduced thermal damage, and improved safety in orthopedic and neurosurgical procedures. With a focus on minimizing soft tissue injury and accelerating recovery, Surgify Halo™ aligns with the growing demand for minimally invasive surgical solutions. The company targets a global orthopedic market valued at over $50 billion, as well as the neurosurgery segment, where precise bone work is paramount. Though still in a relatively early commercial stage, Surgify Medical has established a strong intellectual property moat and benefits from Finland's advanced medtech ecosystem. Its technology has the potential to become a standard tool in operating rooms worldwide, competing against legacy devices from incumbents like Stryker and Medtronic, but with a differentiated value proposition in safety and precision.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for Surgify Halo™ in the U.S.60% success
• Q4 2026CE Mark certification for European market entry70% success
• 2026Strategic partnership or distribution agreement with a major orthopedic company40% success